Author:
Kwon Hyewon,Crisostomo Amanda C.,Smalls Hayley Marie,Finke John M.
Publisher
Public Library of Science (PLoS)
Reference66 articles.
1. The public health impact of Alzheimer's disease, 2000–2050: potential implication of treatment advances;PD Sloane;Annu Rev Public Health,2002
2. Kyhos B, Spak D (2013). "GAP 18-Month Study Results, http://www.baxter.com/gap/baxter_gap_study_data_table.pdf.".
3. Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial;R Dodel;Lancet Neurol,2013
4. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease;RS Doody;N Engl J Med,2014
5. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease;S Salloway;N Engl J Med,2014
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献